deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00247624

Improving Sleep and Psychological Functioning in People With Depression and Insomnia

Hypnotics in the Treatment of Psychiatric Disorders

Sponsor: National Institute of Mental Health (NIMH)

Conditions Depression Sleep Initiation and Maintenance Disorders
Interventions Eszopiclone Fluoxetine Placebo
Updated 10 times since 2017 Last updated: Jul 30, 2018 Started: Oct 31, 2005 Primary completion: Oct 31, 2008 Completion: Dec 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Depression and Sleep Initiation and Maintenance Disorders, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 10 data snapshots since 2005. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshotUnknown Status~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotCompleted~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotCompleted~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Sep 2023 · 8 months · monthly snapshotCompleted~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2023 — Sep 2023 [monthly]

    Completed PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

▶ Show 5 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

  2. Sep 2018 — Jan 2021 [monthly]

    Completed PHASE4

  3. Jun 2018 — Sep 2018 [monthly]

    Completed PHASE4

  4. Dec 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: Unknown Status → Completed

  5. Jan 2017 — Dec 2017 [monthly]

    Unknown Status PHASE4

    First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
  • Philips Healthcare
  • Sumitomo Pharma America, Inc.
  • Wake Forest University Health Sciences
Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations